Undervalued Health care stocks, tonight
Drugs, devices, hospitals, and insurers. Skip if you do not follow biotech.
Prices from Tuesday’s close (6 October).
Start with a ready-made list
- Safe and steadyStrong businesses with little debt and no serious warning signs.10 companies
- Cheap, and insiders are buyingBosses bought shares with their own money in the last 90 days.5 companies
- Owned by famous fundsAt least two of the funds we track hold it.49 companies
- Bargains near their 1-year lowStrong enough for our list and close to a 1-year low.6 companies
- Paid to waitPays a dividend of 2% or more, with low debt.1 company
Size
Index
Signals
Picks
- Near its 1-year low. The price is within 10% of its lowest point in the past year.
- Low debt. Owes less than half of what the business is worth on its books. Banks and insurers are left out.
- Growing steadily. Sales grew at least 5% a year for five years, with spare cash every year.
- Best businesses only. Only the companies that score 85 or more out of 100 on quality.
Pays you cash each year. 4% means $4 a year for every $100 of shares.
WarningsKeeps companies we fully checked that show none of these serious signs: doubt it can keep going, weak checks on its own accounts, or a notice that its past accounts can't be relied on. One big customer or a new auditor doesn't remove a company: those are only worth knowing. We don't check lawsuits, investigations or debt yet.
Hide companies with…
We read each company's latest annual report and recent SEC notices for these five signs only.
55 companies match
| Company | What they do | Price | Market value | Cash yield | Price to profit | Return on capital | Funds | Score | Compare | |
|---|---|---|---|---|---|---|---|---|---|---|
| PfizerPFECluster buy | Pfizer sells medicines and vaccines to patients, doctors, and governments. | $27.5016% above 1-year low | $156.7bn | 7.0% | 12.4× | 5.8% | 25 | 1.24 | See why | |
| ZoetisZTS | Zoetis sells animal medicines and vaccines to pet owners, veterinarians, and livestock producers. | $71.334% above 1-year low | $29.5bn | 7.7% | 10.5× | 28.0% | 19 | 1.08 | See why | |
| InModeINMD | Electromedical & electrotherapeutic apparatus | $13.9910% above 1-year low | $886m | 9.5% | 6.8× | 24.0% | 4 | 1.05 | See why | |
| HCA HealthcareHCA | HCA Healthcare sells hospital care, surgery and emergency services to patients in the United States. | $432.2022% above 1-year low | $93.6bn | 6.4% | 11.7× | 23.2% | 17 | 1.04 | See why | |
| InnovivaINVA | Innoviva sells hospital drugs to hospitals and earns royalties from GSK. | $20.8326% above 1-year low | $1.5bn | 12.6% | 7.3× | 15.8% | 5 | 1.01 | See why | |
| Boston ScientificBSXCluster buy | Boston Scientific sells medical devices to hospitals, doctors, and healthcare providers. | $42.19at 1-year low | $61.1bn | 5.9% | 17.6× | 6.4% | 11 | 1.00 | See why | |
| Harmony Biosciences HoldingsHRMY | Harmony Biosciences sells narcolepsy medicine to patients with sleep disorders. | $39.3654% above 1-year low | $2.3bn | 15.2% | 8.2× | 43.5% | 6 | 1.00 | See why | |
| Nutex HealthNUTXSerious warning sign | Nutex Health sells hospital and doctor care to patients and insurers. | $218.40160% above 1-year low | $1.5bn | 18.3% | 4.4× | 26.1% | 1 | 0.98 | See why | |
| Amphastar PharmaceuticalsAMPH | Amphastar sells generic injectable, inhalation, and nasal medicines to hospitals and patients. | $25.9156% above 1-year low | $1.1bn | 13.9% | 13.0× | 13.8% | 4 | 0.97 | See why | |
| Regeneron PharmaceuticalsREGN | Regeneron Pharmaceuticals sells prescription medicines to patients and doctors. | $738.7237% above 1-year low | $80.2bn | 4.7% | 20.9× | 12.3% | 10 | 0.91 | See why | |
| MerckMRK | Merck sells medicines, vaccines, and animal health products to wholesalers, hospitals, doctors and governments. | $141.9473% above 1-year low | $350.2bn | 4.6% | 18.5× | 20.3% | 29 | 0.89 | See why | |
| Universal Health ServicesUHS | Universal Health Services runs hospitals and clinics that treat patients, billing insurers and government health programs. | $177.0826% above 1-year low | $11.4bn | 7.4% | 7.9× | 10.5% | 9 | 0.88 | See why | |
| Gilead SciencesGILD | Gilead Sciences sells medicines for HIV, hepatitis, COVID-19, and cancer to patients and doctors. | $144.2328% above 1-year low | $178.8bn | 7.2% | 16.1× | 14.4% | 12 | 0.88 | See why | |
| Tenet HealthcareTHC | General medical & surgical hospitals, nec | $258.4764% above 1-year low | $20.8bn | 14.5% | 7.0× | 15.8% | 7 | 0.86 | See why | |
| Zimmer Biomet HoldingsZBH | Zimmer Biomet sells knee and hip replacements to hospitals and surgeons. | $89.6813% above 1-year low | $17.1bn | 8.9% | 20.1× | 4.4% | 15 | 0.85 | See why | |
| DavitaDVA | DaVita provides dialysis and kidney care services to people with kidney disease. | $180.4079% above 1-year low | $11.5bn | 14.0% | 10.2× | 15.4% | 5 | 0.85 | See why | |
| ResmedRMD | ResMed sells sleep apnea devices, ventilators, masks, and software to patients, clinics, and hospitals. | $220.6922% above 1-year low | $31.8bn | 5.2% | 16.4× | 20.5% | 3 | 0.84 | See why | |
| GE HealthCare TechnologiesGEHC | GE HealthCare sells medical devices, software, and services to hospitals and researchers. | $64.7710% above 1-year low | $29.3bn | 5.4% | 13.7× | 12.9% | 18 | 0.83 | See why | |
| Encompass HealthEHC | Encompass Health runs inpatient rehabilitation hospitals for people recovering from injury or illness. | $124.6934% above 1-year low | $12.3bn | 3.4% | 12.9× | 13.8% | 4 | 0.81 | See why | |
| SBC Medical Group HoldingsSBCSerious warning sign | Offices & clinics of doctors of medicine | $5.3392% above 1-year low | $548m | 11.3% | 6.1× | n/a | 0 | 0.80 | See why | |
| Prestige Consumer HealthcarePBH | Prestige Consumer Healthcare sells packaged foods and cereals to grocery retailers and consumers. | $46.449% above 1-year low | $2.2bn | 10.7% | 14.3× | 8.6% | 8 | 0.80 | See why | |
| Pacira BioSciencesPCRXNew | Pharmaceutical preparations | $24.7632% above 1-year low | $987m | 18.2% | 6.3× | 2.6% | 2 | 0.79 | See why | |
| Addus HomeCareADUS | Addus HomeCare sells home care services to government agencies, insurers, and individuals. | $113.1629% above 1-year low | $2.1bn | 7.3% | 14.0× | 8.3% | 3 | 0.79 | See why | |
| IncyteINCY | Incyte sells prescription medicines to patients with cancer and immune diseases. | $112.7336% above 1-year low | $22.9bn | 8.4% | n/a | n/a | 6 | 0.77 | See why | |
| Lantheus HoldingsLNTH | Lantheus Holdings sells imaging drugs and cancer drugs to hospitals and clinics. | $99.95101% above 1-year low | $6.5bn | 5.9% | 21.5× | 18.9% | 8 | 0.76 | See why |
30 more match your filters
A free account shows the full list, remembers these filters, and emails you when a new company enters them. No card.